¼¼°èÀÇ PBM(Pharmacy Benefit Management) ½ÃÀå ±Ô¸ð Á¶»ç ¹× ¿¹Ãø : ¼­ºñ½ºº°, ¼­ºñ½º °ø±ÞÀÚº°, Áö¿ªº° ºÐ¼®(2023-2030³â)
Global Pharmacy Benefit Management Market Size Study & Forecast, by Service, by Service Provider, and Regional Analysis, 2023-2030
»óǰÄÚµå : 1407966
¸®¼­Ä¡»ç : Bizwit Research & Consulting LLP
¹ßÇàÀÏ : 2023³â 12¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,950 £Ü 6,991,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 6,250 £Ü 8,828,000
Printable PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°è PBM(Pharmacy Benefit Management) ½ÃÀå ±Ô¸ð´Â 2022³â ¾à 5,139¾ï 8,000¸¸ ´Þ·¯·Î ¿¹ÃøµÇ¸ç, ¿¹Ãø ±â°£ÀÎ 2023-2030³â µ¿¾È 6.0% ÀÌ»óÀÇ °ÇÀüÇÑ ¼ºÀå·üÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. PBM(Pharmacy Benefit Management)´Â ÀÇ·á º¸Çè»ç, °í¿ëÁÖ ¹× ±âŸ ÁöºÒÀÎÀ» À§ÇØ Ã³¹æ¾à ÇýÅÃÀ» °ü¸®ÇÏ´Â ÇÁ·Î¼¼½ºÀÔ´Ï´Ù.

PBMÀº ÀǾàǰÀÇ Ã³¹æ ¼³°è ¹× °ü¸®, Á¦Á¶»ç¿ÍÀÇ ¾à°¡ Çù»ó, 󹿾à û±¸ ó¸® ¹× Á¤»êÀ» ´ã´çÇϸç, ȯÀÚ, ¾à»ç, Á¦¾à»ç, º¸Çè»ç µî ÀÇ·á½Ã½ºÅÛ¿¡ °ü¿©ÇÏ´Â ¿©·¯ ÀÌÇØ°ü°èÀÚÀÇ Áß°³ÀÚ ¿ªÇÒÀ» ÇÕ´Ï´Ù. 󹿾à ÁöÃâ°ú »ç¿ë·®À» ÁÙÀÏ ¼ö ÀÖµµ·Ï Áö¿øÇÏ´Â °ÍÀÌ ÁÖ¿ä ¸ñÀûÀÔ´Ï´Ù. PBM(Pharmacy Benefit Management) ½ÃÀåÀÇ ¼ºÀå ¹è°æ¿¡´Â ¿öÅ©Ç÷ο츦 ¿øÈ°ÇÏ°Ô Çϱâ À§ÇÑ ¸Ó½Å·¯´×°ú ÀΰøÁö´ÉÀÇ µµÀÔ Áõ°¡, ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡, µ¥ÀÌÅÍ ºÐ¼®, º¹¾à ¼øÀÀµµ¿Í °Ç°­ °á°ú¿¡ ´ëÇÑ °ü½É Áõ°¡, ó¹æ¾à »ç¿ë Áõ°¡ µîÀÇ ¿äÀÎÀÌ ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¾à±¹ ÇýÅà °ü¸®¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ¾à±¹ ¿î¿µÀÇ Á¤È®¼º, ¾ÈÀü¼º, È¿À²¼ºÀ» °­È­ÇÏ¿© ±Ã±ØÀûÀ¸·Î ȯÀÚÀÇ °Ç°­ »óŸ¦ °³¼±ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå È®´ë¸¦ ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¶ÇÇÑ, Àü ¼¼°è ÀÇ·áºñ ÁöÃâÀÌ ±ÞÁõÇÔ¿¡ µû¶ó ÀǾàǰ Àç°í ¹× °ø±Þ °ü¸®¿Í ȯÀڵ鿡°Ô ºñ¿ë È¿À²ÀûÀÎ ÀǾàǰ °ø±ÞÀ» À§ÇÑ Ã·´Ü ¼ÒÇÁÆ®¿þ¾î ¹× ¼Ö·ç¼ÇÀÇ Ã¤ÅÃÀÌ Áõ°¡ÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ÀÌ´Â ÇâÈÄ ¸î ³â µ¿¾È ½ÃÀå È®´ë¿¡ ¹ÚÂ÷¸¦ °¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¹Ì±¹ ¸ÞµðÄÉ¾î ¹× ¸ÞµðÄÉÀÌµå ¼­ºñ½º ¼¾ÅÍ(Centers for Medicare and Medicaid Services)°¡ ¹ßÇ¥ÇÑ 2021³â ÀÚ·á¿¡ µû¸£¸é, 2021³â ±¹¹Î ÀÇ·áºñ ÁöÃâÀº 2.7% Áõ°¡ÇÏ¿© 4Á¶ 3,000¾ï ´Þ·¯(±¹¹Î 1Àδç 12,914´Þ·¯)¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óÇß½À´Ï´Ù. GDPÀÇ 18.3%¸¦ Â÷ÁöÇÕ´Ï´Ù. ¶ÇÇÑ 2021³â ¹Î°£ ÀǷẸÇè ÁöÃâÀº 5.8% Áõ°¡ÇÑ 1Á¶ 2,114¾ï ´Þ·¯, 󹿾à ÁöÃâÀº 7.8% Áõ°¡ÇÑ 3,780¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. µû¶ó¼­ ¾Õ¼­ ¾ð±ÞÇÑ ¿äÀεéÀº ¿¹Ãø ±â°£ µ¿¾È PBM(Pharmacy Benefit Management) ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÈ­ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, °í±Þ ¼ÒÇÁÆ®¿þ¾î ¹× ¼Ö·ç¼Ç °³¹ß¿¡ ´ëÇÑ °­Á¶´Â ó¹æÀü Á¦Ç°¿¡ ´ëÇÑ °­·ÂÇÑ ¼ö¿ä¿Í ÇÔ²² ¿¹Ãø ±â°£ µ¿¾È ´Ù¾çÇÑ À¯¸®ÇÑ ±âȸ¸¦ °¡Á®¿Ã °ÍÀÔ´Ï´Ù. ±×·¯³ª ¾ö°ÝÇÑ Á¤ºÎ ±ÔÁ¦¿Í ÀǾàǰ °¡°Ý »ó½ÂÀº 2023-2030³â ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀÇ °É¸²µ¹·Î ÀÛ¿ëÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

¼¼°è PBM(Pharmacy Benefit Management) ½ÃÀå Á¶»ç¿¡¼­ °í·ÁµÈ ÁÖ¿ä Áö¿ªÀ¸·Î´Â ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«°¡ ÀÖ½À´Ï´Ù. ºÏ¹Ì´Â ¾à¹° ¿À³²¿ë Áõ°¡, ¾à±¹ ÇýÅà °ü¸® µµÀÔ Áõ°¡, ÀÇ·áºñ ÁöÃâ Áõ°¡·Î ÀÎÇØ 2022³â ½ÃÀåÀ» Àå¾ÇÇß½À´Ï´Ù. ¿¹¸¦ µé¾î, ¿Á½ºÆ÷µå ´ëÇÐ ÃâÆÇºÎ°¡ 2022³â 7¿ù¿¡ ¹ßÇ¥ÇÑ ¿¬±¸¿¡ µû¸£¸é ¹Ì±¹ÀÇ Ã³¹æ¾à ÁöÃâÀº 2022³â¿¡ Àü³âµµ 4%¿¡¼­ 6%·Î Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óÇß½À´Ï´Ù. ÀÌ·¯ÇÑ ÁöÃâ Áõ°¡´Â ÀÌ Áö¿ªÀÇ Ã³¹æ¾à ¼ö¿ä Áõ°¡¸¦ µÞ¹ÞħÇϰí ÀÖÀ¸¸ç, ÀÌ´Â ¾à±¹ °ü¸® ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇÏ°í ½ÃÀå ¼ºÀå¿¡ ±â¿©ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, ÀǷẸÇè¿¡ °¡ÀÔÇÑ Àα¸°¡ ¸¹°í, ¾à±¹ ÇýÅà °ü¸®ÀÚ¿¡ ´ëÇÑ Á¤ºÎÀÇ ±ÔÁ¦°¡ °­È­µÇ°í ÀÖÀ¸¸ç, ¾à±¹ ÇýÅà °ü¸® ±â¾÷ÀÇ ¼ö°¡ Áõ°¡Çϰí ÀÖ´Â °Íµµ ÀÌ Áö¿ªÀÇ °­Á¡ÀÔ´Ï´Ù. ¹Ý¸é, ¼¼°è ´Ù¸¥ Áö¿ªÀº ¿¹Ãø ±â°£ µ¿¾È ³ôÀº CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. °Ç°­ ÀÎ½Ä °³¼± ³ë·ÂÀÇ È®»ê°ú º¸Çè»çÀÇ ÀÇ·á Ç÷£ ¼±ÅÃ±Ç È®´ë´Â ¾à±¹ ¼­ºñ½º ÀÌ¿ëÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ÀÇ·á ½Ã½ºÅÛÀÇ º¹À⼺ ¶ÇÇÑ ÀÌ Áö¿ªÀÇ ½ÃÀå ¼ö¿ä¸¦ Å©°Ô ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

ÀÌ Á¶»çÀÇ ¸ñÀûÀº ÃÖ±Ù ¸î ³â µ¿¾È ´Ù¾çÇÑ ºÎ¹®°ú ±¹°¡ÀÇ ½ÃÀå ±Ô¸ð¸¦ ÆÄ¾ÇÇϰí ÇâÈÄ ¸î ³â µ¿¾È ½ÃÀå ±Ô¸ð¸¦ ¿¹ÃøÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÌ º¸°í¼­´Â Á¶»ç ´ë»ó ±¹°¡ÀÇ »ê¾÷ÀÇ ÁúÀû, ¾çÀû Ãø¸éÀ» Æ÷ÇÔÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù.

¶ÇÇÑ ½ÃÀåÀÇ ¹Ì·¡ ¼ºÀåÀ» ±ÔÁ¤ÇÏ´Â ÃËÁø¿äÀΰú °úÁ¦¿Í °°Àº Áß¿äÇÑ Ãø¸é¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ Á¤º¸µµ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ, ÁÖ¿ä ±â¾÷ÀÇ °æÀï »óȲ°ú Á¦Ç° Á¦°ø¿¡ ´ëÇÑ »ó¼¼ÇÑ ºÐ¼®°ú ÇÔ²² ÀÌÇØ°ü°èÀÚµéÀÌ ÅõÀÚÇÒ ¼ö ÀÖ´Â ¹Ì½ÃÀû ½ÃÀå¿¡¼­ÀÇ ÀáÀçÀû ±âȸµµ Æ÷ÇÔÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼¼°èÀÇ PBM(Pharmacy Benefit Management) ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§

Á¦3Àå ¼¼°èÀÇ PBM(Pharmacy Benefit Management) ½ÃÀå ¿ªÇÐ

Á¦4Àå ¼¼°èÀÇ PBM(Pharmacy Benefit Management) ½ÃÀå »ê¾÷ ºÐ¼®

Á¦5Àå PBM(Pharmacy Benefit Management) ¼¼°è ½ÃÀå : ¼­ºñ½ºº°

Á¦6Àå PBM(Pharmacy Benefit Management) ¼¼°è ½ÃÀå : ¼­ºñ½º Á¦°øÀÚº°

Á¦7Àå PBM(Pharmacy Benefit Management) ¼¼°è ½ÃÀå : Áö¿ªº° ºÐ¼®

Á¦8Àå °æÀï Á¤º¸

Á¦9Àå Á¶»ç °úÁ¤

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Pharmacy Benefit Management (PBM) Market is at approximately USD 513.98 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 6.0% over the forecast period 2023-2030. Pharmacy Benefit Management (PBM) is the process of managing prescription drug benefits for health insurers, employers, and other payers. PBMs design and maintain drug formularies, bargain drug pricing with manufacturers, and handle and settle claims for prescription medications. PBMs operate as go-betweens for many parties involved in the healthcare system, such as patients, pharmacists, medication makers, and insurance companies. Their main objective is to support the reduction of prescription drug expenditures and utilization while ensuring that patients have access to essential treatments. The Pharmacy Benefit Management (PBM) Market is expanding because of factors such as the increasing adoption of machine learning and artificial intelligence to smoothen workflow, increasing prevalence of chronic diseases, rising focus on data analytics, medication adherence and health outcomes, and growing prescription drug utilization. Also, the growing emphasis on pharmacy benefits management is expected to enhance the precision, safety, and efficiency of pharmacy operations, ultimately leading to better patient health outcomes. This trend is projected to stimulate market expansion throughout the forecast period.

In addition, the surge in global healthcare expenditures is poised to drive the adoption of advanced software and solutions for drug inventory and supply management, as well as the provision of cost-effective medications to patients. This is expected to fuel market expansion in the anticipated years. As per 2021 data released by the Centers for Medicare and Medicaid Services, national health spending escalated by 2.7% to reach USD 4.3 trillion in 2021 (equivalent to USD 12,914 per capita), representing 18.3% of the GDP. Furthermore, private health insurance spending rose by 5.8% to USD 1,211.4 billion, and prescription drug expenditure surged by 7.8% to reach USD 378 billion in 2021. Accordingly, these aforementioned factors are accelerating the growth of the Pharmacy Benefit Management (PBM) Market during the estimated period. Furthermore, the rising emphasis on developing advanced software and solutions, along with the robust demand for prescription products present various lucrative opportunities over the forecast years. However, the stringent government regulations and the rising drug prices are challenging the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Pharmacy Benefit Management (PBM) Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the rising number of medication errors, increasing adoption of pharmacy benefit management, and an upward trajectory in healthcare spending. For instance, in a study published by Oxford University Press in July 2022, it was stated that the overall prescription drug spending in the United States was projected to increase from 4% in the previous year to 6% in 2022. This heightened expenditure underscores the strong demand for prescription drugs in the region, which is expected to drive the demand for pharmacy management systems and, thus, contribute to market growth. Also, the substantial population under medical coverage, supportive government regulations for pharmacy benefit managers, and a growing number of pharmacy benefit management companies in the country further contribute to the region's dominance. Whereas, the rest of the world is expected to grow at a significant CAGR over the forecast years. The growing prevalence of health awareness initiatives and the expansion of health plan options by insurance providers are expected to stimulate the uptake of pharmacy services, as well as the increasing complexity of the healthcare system is significantly propelling the market demand across the region.

Major market players included in this report are:

Recent Developments in the Market:

Global Pharmacy Benefit Management (PBM) Market Report Scope:

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Service:

By Service Provider:

By Region:

Table of Contents

Chapter 1. Executive Summary

Chapter 2. Global Pharmacy Benefit Management (PBM) Market Definition and Scope

Chapter 3. Global Pharmacy Benefit Management (PBM) Market Dynamics

Chapter 4. Global Pharmacy Benefit Management (PBM) Market Industry Analysis

Chapter 5. Global Pharmacy Benefit Management (PBM) Market, by Service

Chapter 6. Global Pharmacy Benefit Management (PBM) Market, by Service Provider

Chapter 7. Global Pharmacy Benefit Management (PBM) Market, Regional Analysis

Chapter 8. Competitive Intelligence

Chapter 9. Research Process

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â